011054 Niacinamide 4% / Spironolactone 5%
Product Images NDC 72934-1205

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for 011054 Niacinamide 4% / Spironolactone 5% (NDC 72934-1205). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sincerus Florida, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

A (2 End)

Side label of 011054 NIACINAMIDE 4% / SPIRONOLACTONE 5% displaying usage directions and manufacturer details. It instructs to use as directed by a physician, apply topically, and wash hands after use. Labeler is Sincerus Florida, LLC, located in Pompano Beach, FL. Includes contact information and FDA MedWatch reporting instructions.*

FDA Label Image

S (1205 2 Front)

Bottle of 011054 NIACINAMIDE 4% / SPIRONOLACTONE 5% topical gel 30gm. The label includes the NDC number 72934-1205-2 and the Sincerus Florida, LLC logo. The product is identified as a compounded drug made in the USA.*

FDA Label Image

S (1205 2 Middle)

Bottle label of 011054 Niacinamide 4% / Spironolactone 5% topical gel showing active and inactive ingredients. Active ingredients include Niacinamide USP 4% and Spironolactone USP 5%. Inactive ingredients listed are Glycerin USP 5%, Lavender Oil 0.25%, and Suspendisse Gel 84.5%. Labeler is Sincerus Florida, LLC.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.